REQUEST A DEMO
Total
USD $0.00
Search more companies

Shenzhen Hepalink Pharmaceutical Group Co.,Ltd (深圳市海普瑞药业集团股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shenzhen Hepalink Pharmaceutical Group Co.,Ltd Profile Updated: March 15, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Shenzhen Hepalink Pharmaceutical Group Co., Ltd is a biopharmaceutical company that operates in over 45 countries and regions worldwide. Hepalink's core business includes heparin industrial chain, large molecule biologics CDMO services, and the research, development, and commercialization of innovative drugs. The company specializes in the development and manufacturing of naturally derived pharmaceuticals and claims to have a strong presence in the global market, with its enoxaparin sodium injection approved in over 40 countries and regions.

Headquarters
No. 21, Langshan Road, Songping Mountain, Nanshan District, Shenzhen, Guangdong Province
Shenzhen; Guangdong; Postal Code: 518057

Contact Details: Purchase the Shenzhen Hepalink Pharmaceutical Group Co.,Ltd (深圳市海普瑞药业集团股份有限公司) report to view the information.

Website: http://www.hepalink.com

Basic Information
Total Employees:
Purchase the Shenzhen Hepalink Pharmaceutical Group Co.,Ltd (深圳市海普瑞药业集团股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Shenzhen Hepalink Pharmaceutical Group Co.,Ltd (深圳市海普瑞药业集团股份有限公司) report to view the information.
Registered Capital:
Purchase the Shenzhen Hepalink Pharmaceutical Group Co.,Ltd (深圳市海普瑞药业集团股份有限公司) report to view the information.
Financial Auditors:
Purchase the Shenzhen Hepalink Pharmaceutical Group Co.,Ltd (深圳市海普瑞药业集团股份有限公司) report to view the information.
Incorporation Date:
April 21, 1998
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
32.31%
Purchase this report to view the information.
27.81%
Purchase this report to view the information.
15%
Purchase this report to view the information.
3.16%
Purchase this report to view the information.
2.75%
Subsidiaries
Chengdu Shenrui Animal Products Co., Ltd.
100%
Cytovance Biologics,Inc
100%
Cytovance Cayman,Inc.
100%
Company Performance
Financial values in the chart are available after Shenzhen Hepalink Pharmaceutical Group Co.,Ltd (深圳市海普瑞药业集团股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
3.09%
Total Operating Revenue
-4.09%
Operating Profit
-28.8%
Net Profit/Loss for the Period
-29.07%
Total Assets
-5.48%
Total Equity
1.73%
Operating Profit Margin
-6.86%
Net Profit Margin
-5.97%
Return on Equity (ROE)
-1.93%
Debt / Equity
-7.38%
Quick Ratio
0.14%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?